Publications
77 publications
Funding
4 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- MPINeoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal CancerNCI · 2024–2029 · via NIH RePORTERR01CA288880-03
- PIDose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancerNCI · 2022–2027 · via NIH RePORTERU01CA271287-04
Completed grants (2)
- MPIImproving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)NCI · 2020–2025 · via NIH RePORTERU01CA238444-05
- PINeoadjuvant PD-1 blockade in mismatch repair deficient rectal cancerNCI · 2021–2024 · via NIH RePORTERR21CA252519-02